Current filters:


Popular Filters

6750 to 6774 of 6948 results

Shire drops Dermagraft for venous leg ulcers, after Ph III failure


Ireland-headquartered drugmaker Shire (LSE: SHP) says that Advanced BioHealing (ABH), the USA-based regenerative…

Advanced BioHealingBiotechnologyDermagraftDermatologicalsPharmaceuticalRegulationResearchShire

Cambridge, UK, spin-out MISSION Therapeutics gets £6 million funding


A team led by Stephen Jackson together with the UK’s Cancer Research Technology (Cancer Research…

EuropeFinancialMISSION TherapeuticsOncologyPharmaceuticalResearch

Jordan’s Hikma delivers 10.4% sales growth in first half 2011


Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported interim results for the six months…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Allergan gets US FDA nod for Botox to treat form of urinary incontinence


There was a boost for US specialty drug firm Allergan (NYSE: AGN) yesterday when the company revealed…

AllerganBotoxNeurologicalNorth AmericaPharmaceuticalRegulation

Spain hopes to save 2.4 billion euros by ordering doctors to Rx generics


As part of moves to reduce the nation’s budget deficit, Spain’s socialist government has passed…


US govt tightens financial conflict of interest rules for medical researchers


The US Department of Health and Human Services this week issued an updated Final Rule on conflict of…

FinancialNorth AmericaPharmaceuticalRegulationResearch

Diabetes treatments now 8.4% of UK annual NHS drugs bill, says report


Diabetes prescriptions now account for 8.4 per of the entire National Health Service net bill for primary…

DiabetesEuropeHealthcareMarkets & MarketingPharmaceuticalPricing

UAE pharmaceutical industry set to benefit from lifestyle changes


A recent Dubai Chamber of Commerce and Industry study indicates that the United Arab Emirates (UAE) pharmaceutical…

GenericsHealthcareMarkets & MarketingPharmaceuticalRest of the World

Trudeau Institute discovers how FluMist elicits protection


New research from the USA-based Trudeau Institute may help to explain why live attenuated influenza vaccine…


Slow growth forecast for asthma therapeutics market to 2018


The global asthma therapeutics market was valued at $14.4 billion in 2010, and is forecast to grow at…

Markets & MarketingPharmaceuticalResearchRespiratory and Pulmonary

AstraZeneca breast cancer drug Faslodex not good use of NHS resources, says NICE draft guidance


An independent committee of experts that develops guidance on behalf of the UK drugs watchdog the National…


CEL-SCI in deal to market Multikine in Argentina and Venezuela


US drug developer CEL-SCI Corp (NYSE AMEX: CVM) has entered into an exclusive sales, marketing and distribution…

BiotechnologyCEL-SCI CorpIDC-GP PharmLicensingOncologyPharmaceuticalSouth America

Changing the mood of Brazilian antidepressant market; fake Levitra


The Vice President of Brazil’s Superior Court of Justice (STJ), Minister Felix Fischer, has restored…

BayerGenericsLevitraLexaproLundbeckNeurologicalPharmaceuticalRegulationReproductiveSouth America

USA’s Public Citizen calls for strongest warnings on PPIs, saying they are over-Rxed


In a petition sent to the US Food and Drug Administration yesterday, consumer advocacy group Public Citizen…

Gastro-intestinalsNorth AmericaPharmaceuticalRegulation

Santarus and Depomed expand US deal on Glumetza


US drugmakers Santarus (Nasdaq: SNTS) and Depomed (Nasdaq: DEPO) have entered into a new commercialization…

DepomedDiabetesGlumetzaLicensingNorth AmericaPharmaceuticalSantarus

US FDA fast-tracks Bayer and Algeta’s prostate drug Alpharadin


Germany’s Bayer (BAY: DE) said this morning that its investigational compound Alpharadin (radium-223…

AlgetaAlpharadinBayerNorth AmericaOncologyPharmaceuticalRegulation

AstraZeneca blood thinner Brilinta now available in USA


Anglo-Swedish pharmaceutical major AstraZeneca (LSE: AZN) said yesterday that Brilinta (ticagrelor) tablets,…

AstraZenecaBrilintaCardio-vascularMarkets & MarketingNorth AmericaPharmaceutical

Nycomed to market Norgine’s laxative MoviPrep in Russia and CIS


Swiss independent drugmaker Nycomed and Netherlands-headquartered Norgine, have entered into a licensing…

EuropeGastro-intestinalsLicensingMarkets & MarketingMoviPrepNorgineNycomedPharmaceutical

6750 to 6774 of 6948 results

Back to top